WeVote
Log In

Bill

Bill

SB 707

Relating to exemption of prescription drug sales; prescribing an effective date.

2025 Regular Session Introduced by Daniel Bonham and 12 co-sponsors

SB 707 would exempt prescription drug sales from Oregon taxation to reduce medication costs, currently pending in Finance and Revenue committee.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · SB 707

Legislative bill overview

SB 707 would exempt prescription drug sales from Oregon's state sales tax or create a new tax exemption category for pharmaceutical purchases. The bill has progressed through initial stages but remains in committee as of mid-2025, with a public hearing held in March but no final action yet taken.

Why is this important

Prescription drug costs are a significant burden for many Oregonians, particularly seniors and uninsured individuals. This exemption could reduce out-of-pocket medication expenses, though the fiscal impact on state revenue would depend on the exemption's scope and the state's current tax structure.

Potential points of contention

  • Revenue impact: Removing or exempting prescription drug sales from taxation reduces state tax revenue, which must be offset through other funding sources or budget cuts
  • Scope ambiguity: The bill's language doesn't clarify whether it covers all medications, only certain categories, or compounded/specialty drugs differently
  • Equity questions: Tax exemptions may disproportionately benefit higher-income individuals with more prescriptions while providing less relief to low-income populations who often receive medications through subsidized programs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.